ArticleBritish journal of cancer2014
Risk factors for delay in symptomatic presentation: a survey of cancer patients.
Article in British journal of cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
103 citing papers in PubMed, 3 syntheses or guidelines pooled it, 175 citations in OpenAlex.
- Associated Factors of Survival Rate and Screening for Colorectal Cancer in Iran: a Systematic Review.Journal of gastrointestinal cancer · 2020Pooled it
- Delays and Barriers to Cancer Care in Low- and Middle-Income Countries: A Systematic Review.The oncologist · 2019Pooled it
- Pooled it
- Targeted encouragement of GP consultations for possible cancer symptoms: a randomised controlled trial.The British journal of general practice : the journal of the Royal College of General Practitioners · 2021Trial
- Which symptoms are linked to a delayed presentation among melanoma patients? A retrospective study.BMC cancer · 2017Trial
- A population-based study on the impact of social determinants of health on time to treatment of stage I lung cancer in Ontario, Canada.BMC cancer · 2026Article
- Observational
- Pilot study of dual-arm absolute quantification of miR-130a and miR-365a in plasma and urine reveals 3p/5p strand-ratio shifts in prostate cancer.Scientific reports · 2026Article
- Memory and thinking problems that aging Latinos in New York City would bring to a doctor's attention.PloS one · 2026Article
- Factors Influencing Time to Treatment Initiation for Breast Cancer in Ethiopia.Cancer medicine · 2025Article
- Article
- Gynaecological oncology services: A qualitative exploration of womens' perspectives at a teaching hospital in North East India.Journal of family medicine and primary care · 2025Article
- Pathways to myeloproliferative neoplasm presentation and time to diagnosis: results from a cross-sectional study.BJGP open · 2025Article
- Relationship between symptoms, sociodemographic factors, and general practice help-seeking in 10 904 adults aged 50 and over.European journal of public health · 2025Article
- Early detection of esophageal cancer: Evaluating AI algorithms with multi-institutional narrowband and white-light imaging data.PloS one · 2025Article
- AEGAN-Pathifier: a data augmentation method to improve cancer classification for imbalanced gene expression data.BMC bioinformatics · 2024Article
- Exophthalmos as the initial presentation of metastatic prostate cancer.Radiology case reports · 2024Article
- Diagnostic experiences of Black and White patients with uterine cancer: A qualitative study.Gynecologic oncology · 2024Article
- Delays in Presentation, Diagnosis, and Treatment Among Patients With GI Cancer in Southwest Nigeria.JCO global oncology · 2024Article
- Early Symptom Patterns by Tumor Laterality, Age at Onset, Stage, and Symptom-to-Treatment Initiation in Patients with Colorectal Cancer.Asian Pacific journal of cancer prevention : APJCP · 2024Article
43 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
Abstract
backgroundDelay in symptomatic presentation leading to advanced stage at diagnosis may contribute to poor cancer survival. To inform public health approaches to promoting early symptomatic presentation, we aimed to identify risk factors for delay in presentation across several cancers.
methodsWe surveyed 2371 patients with 15 cancers about nature and duration of symptoms using a postal questionnaire. We calculated relative risks for delay in presentation (time from symptom onset to first presentation >3 months) by cancer, symptoms leading to diagnosis and reasons for putting off going to the doctor, controlling for age, sex and deprivation group.
resultsAmong 1999 cancer patients reporting symptoms, 21% delayed presentation for >3 months. Delay was associated with greater socioeconomic deprivation but not age or sex. Patients with prostate (44%) and rectal cancer (37%) were most likely to delay and patients with breast cancer least likely to delay (8%). Urinary difficulties, change of bowel habit, systemic symptoms (fatigue, weight loss and loss of appetite) and skin symptoms were all common and associated with delay. Overall, patients with bleeding symptoms were no more likely to delay presentation than patients who did not have bleeding symptoms. However, within the group of patients with bleeding symptoms, there were significant differences in risk of delay by source of bleeding: 35% of patients with rectal bleeding delayed presentation, but only 9% of patients with urinary bleeding. A lump was a common symptom but not associated with delay in presentation. Twenty-eight percent had not recognised their symptoms as serious and this was associated with a doubling in risk of delay. Embarrassment, worry about what the doctor might find, being too busy to go to the doctor and worry about wasting the doctor's time were also strong risk factors for delay, but were much less commonly reported (<6%).
interpretationApproaches to promote early presentation should aim to increase awareness of the significance of cancer symptoms and should be designed to work for people of the lowest socioeconomic status. In particular, awareness that rectal bleeding is a possible symptom of cancer should be raised.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.